Welcome
Support Centre
09 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Antioxidants in the risk of cardiovascular disease
ISRCTN ISRCTN12745004
ClinicalTrials.gov identifier
Public title Antioxidants in the risk of cardiovascular disease
Scientific title An observational cross-sectional cohort study of the protective role of antioxidants against oxidative stress and inflammation in patients with a risk of cardiovascular disease
Acronym AOCARD
Serial number at source 1
Study hypothesis There is a link between plasma concentrations of beta-carotene and alpha-tocopherol, the level of systemic inflammation and oxidative stress in patients with advanced coronary artery disease. Our presumption is that beta-carotene and alpha-tocopherol both hold protective roles against oxidative stress and inflammation.
Lay summary Not provided at time of registration
Ethics approval Hospital Ethical Committee on Human Research of Regional Hospital of Pardubice, Czech Republic approved on the 12th May 2006
Study design Observational cross-sectional cohort study
Countries of recruitment Czech Republic
Disease/condition/study domain Coronary artery disease
Participants - inclusion criteria Participants were recruited from the Department of Cardiology, Regional Hospital of Pardubice.

Group 1:
1.1. Both males and females, aged 45 - 69 years
1.2. Patients with non-acute chest pain
1.3. Significant stenosis (coronary angiography)

Group 2:
2.1. Both males and females, aged 45 - 69 years
2.2. Patients with non-acute chest pain
2.3. No stenosis (coronary angiography)
Participants - exclusion criteria 1. Renal, hepatic or oncologic disease
2. Intake of vitamin and nutrition supplements
Anticipated start date 01/09/2008
Anticipated end date 30/06/2009
Status of trial Completed
Patient information material
Target number of participants 140
Interventions Patients diagnosed with non-acute coronary angiography for chest pain will be entered into the study in one of two groups:
Group 1: significant stenosis of coronary arteries
Group 2: patients without any stenosis

Venous blood was obtained under standard conditions, from 7 to 8 am after fasting for at least 12 hours. For the determination of beta-carotene, alpha-tocopherol and malondialdehyde concentrations, blood was collected in tubes with ethylenediaminetetraacetic acid (EDTA) covered with aluminium foil to avoid carotenoid oxidation and polymerisation by oxygen and light. Plasma was obtained by centrifugation of the blood samples at 1500 g for 20 minutes and immediately stored at -80°C in 1.5 ml amber polypropylene tubes.

A questionnaire was also provided for the evaluation of pharmacotherapy, intake of nutrition or vitamin supplements, smoking or other diseases such as hypertension or diabetes.
Primary outcome measure(s) Measured from standard venous blood collection (see interventions section):
1. Beta-carotene
2. Alpha-tocopherol
3. Malondialdehyde
4. Free radicals
5. High sensitivity c-reactive protein (hsCRP)
6. Interleukin-6 (IL-6)
Secondary outcome measure(s) Measured from standard venous blood collection (see interventions section):
1. High density lipoprotein (HDL)-cholesterol
2. Low density lipoprotein (LDL)-cholesterol
3. Triglycerides
4. Total cholesterol
5. Glucose
6. Fibrinogen
7. Ceruloplasmin
8. Albumin
9. Transferrin
10. Haemoglobin
Sources of funding Ministry of Education, Youth and Sports (Czech Republic) (ref: CR grant COST 926 OC 124; 0021627502)
Trial website
Publications 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/21792817
Contact name Dr  Vladimira  Muzakova
  Address University of Pardubice
Studentska 573
  City/town Pardubice
  Zip/Postcode 532 10
  Country Czech Republic
Sponsor Regional Hospital of Pardubice (Czech Republic)
  Address Kyjevska 44
  City/town Pardubice
  Zip/Postcode 530 02
  Country Czech Republic
  Sponsor website: http://www.nemocnice-pardubice.cz/
Date applied 23/10/2009
Last edited 11/10/2011
Date ISRCTN assigned 19/11/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central